Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial Infarction - Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary PCI on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute MI

Description:

Intracoronary streptokinase (ICSK) has been shown to be associated with improved microperfusion in patients undergoing percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI). The current trial sought to study effects of ICSK on intermediate-term parameters in patients with STEMI.